Company: TXG
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001770787-25-000051
Chunk: 24

Company: 10x Genomics, Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
ConsumablesChromium85,788 94,108 (8,320)(9)169,897 178,035 (8,138)(5)Spatial36,397 29,254 7,143 24 67,644 55,662 11,982 22 Total consumables revenue122,185 123,362 (1,177)(1)237,541 233,697 3,844 2 Services8,475 5,776 2,699 47 16,127 10,993 5,134 47 Products and services revenue145,157 152,990 (7,833)(5)282,980 293,995 (11,015)(4)License and royalty revenue27,751 114 27,637 NM44,811 115 44,696 NMTotal revenue$172,908 $153,104 $19,804 13 %$327,791 $294,110 $33,681 11 %

Products and services revenue decreased $7.8 million, or 5%, to $145.2 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Instruments revenue decreased $9.4 million, or 39%, to $14.5 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Consumables revenue decreased $1.2 million, or 1%, to $122.2 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Services revenue increased $2.7 million, or 47%, for the three months ended June 30, 2025 as compared to three months ended June 30, 2024, primarily driven by an increase in service plans for instruments coming off warranty.

Products and services revenue decreased $11.0 million, or 4%, to $283.0 million for the six months ended June 30, 2025 as compared to the six months ended June 30, 2024. Instruments revenue decreased $20.0 million, or 41%, to $29.3 million for the six months ended June 30, 2025 as compared to the six months ended June 30, 2024